• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将基于碘-125标记葡聚糖微球的植入物注射到兔膀胱后未见远处迁移。

Lack of distant migration after injection of a 125iodine labeled dextranomer based implant into the rabbit bladder.

作者信息

Stenberg A M, Sundin A, Larsson B S, Läckgren G, Stenberg A

机构信息

Department of Obstetrics and Gynecology, Uppsala University Hospital, Sweden.

出版信息

J Urol. 1997 Nov;158(5):1937-41. doi: 10.1016/s0022-5347(01)64185-5.

DOI:10.1016/s0022-5347(01)64185-5
PMID:9334643
Abstract

PURPOSE

In recent years endoscopic treatment of stress incontinence and vesicoureteral reflux has been introduced. Reports of possible particle migration of the injected material to distant organs in humans and experimental animals have led to a search for biological nonmigration products. An implant found to have a good clinical effect in these conditions is dextranomer in hyaluronan. We performed this study in rabbits to investigate the possible migration of dextranomer particles.

MATERIALS AND METHODS

125Iodine labeled dextranomer particles were injected into the submucosal space of rabbit bladders, and samples of blood and various tissues were examined for radioactivity at scheduled intervals during a 28-day period. Furthermore, whole body autoradiography was performed 1 day, and 1 and 4 weeks after injection.

RESULTS

Radioactivity was found in blood samples and in all tissues but it remained at the background activity level except in the thyroid, where uptake representing free 125iodine was detected. In the bladder 41 and 45% of the injected dose remained within the bladder wall 1 day and 4 weeks, respectively, after injection. The remainder of the dose probably disappeared from the bladder wall by leakage into the urine shortly after deposition, as indicated by the finding of 10-fold higher urine radioactivity levels at day 1 than at day 28 after injection.

CONCLUSIONS

No distant migration of dextranomer particles occurs after submucosal injection of such an implant in the rabbit bladder wall.

摘要

目的

近年来,压力性尿失禁和膀胱输尿管反流的内镜治疗方法已被引入。有报道称,在人类和实验动物中,注射材料的颗粒可能会迁移至远处器官,这促使人们寻找不会发生迁移的生物材料。一种在这些病症中显示出良好临床效果的植入物是透明质酸葡聚糖微球。我们在兔子身上进行了这项研究,以调查葡聚糖微球颗粒是否可能发生迁移。

材料与方法

将碘-125标记的葡聚糖微球颗粒注射到兔膀胱黏膜下层,在28天的时间内按预定间隔对血液和各种组织样本进行放射性检测。此外,在注射后1天、1周和4周进行全身放射自显影。

结果

在血液样本和所有组织中均检测到放射性,但除甲状腺外,放射性均维持在本底活性水平,甲状腺中检测到代表游离碘-125的摄取。注射后1天和4周,分别有41%和45%的注射剂量留在膀胱壁内。注射后第1天尿液中的放射性水平比第28天高10倍,这表明其余剂量可能在沉积后不久通过漏入尿液而从膀胱壁消失。

结论

在兔膀胱壁黏膜下注射此类植入物后,葡聚糖微球颗粒不会发生远处迁移。

相似文献

1
Lack of distant migration after injection of a 125iodine labeled dextranomer based implant into the rabbit bladder.将基于碘-125标记葡聚糖微球的植入物注射到兔膀胱后未见远处迁移。
J Urol. 1997 Nov;158(5):1937-41. doi: 10.1016/s0022-5347(01)64185-5.
2
The biological behavior of autologous collagen injected into the rabbit bladder.
J Urol. 1995 Aug;154(2 Pt 2):808-11. doi: 10.1097/00005392-199508000-00129.
3
Risk factors for urinary tract infection after dextranomer/hyaluronic acid endoscopic injection.葡聚糖/透明质酸内镜注射后尿路感染的危险因素。
J Urol. 2009 Oct;182(4 Suppl):1708-12. doi: 10.1016/j.juro.2009.02.088. Epub 2009 Aug 18.
4
Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings.用葡聚糖-透明质酸进行内镜治疗膀胱输尿管反流:组织学结果
J Urol. 2003 Mar;169(3):1109-13. doi: 10.1097/01.ju.0000053013.49676.89.
5
Endoscopic treatment with stabilized nonanimal hyaluronic acid/dextranomer gel is effective in vesicoureteral reflux associated with bladder dysfunction.使用稳定化非动物透明质酸/葡聚糖凝胶进行内镜治疗对与膀胱功能障碍相关的膀胱输尿管反流有效。
J Urol. 2007 Mar;177(3):1124-8; discussion 1128-9. doi: 10.1016/j.juro.2006.10.094.
6
Endoscopic treatment of urinary incontinence in pediatric patients: 2-year experience with dextranomer/hyaluronic acid copolymer.小儿尿失禁的内镜治疗:右旋糖酐/透明质酸共聚物的2年经验
J Urol. 2002 Oct;168(4 Pt 2):1868-71. doi: 10.1097/00005392-200210020-00050.
7
Febrile urinary tract infections after ureteroneocystostomy and subureteral injection of dextranomer/hyaluronic acid for vesicoureteral reflux--do choice of procedure and success matter? ureteroneocystostomy 术后和下尿路注射葡聚糖/透明质酸治疗膀胱输尿管反流并发发热性尿路感染——手术方法和成功率重要吗?
J Urol. 2013 Jan;189(1):275-82. doi: 10.1016/j.juro.2012.09.011. Epub 2012 Nov 20.
8
Factors affecting the success of endoscopic treatment of vesicoureteral reflux and comparison of two dextranomer based bulking agents: does bulking substance matter?影响膀胱输尿管反流内镜治疗成功的因素及两种基于葡聚糖omer的填充剂的比较:填充物质重要吗?
J Pediatr Urol. 2015 Apr;11(2):90.e1-5. doi: 10.1016/j.jpurol.2014.12.009. Epub 2015 Mar 2.
9
The cost-effectiveness of endoscopic injection of dextranomer/hyaluronic acid copolymer for vesicoureteral reflux.内镜注射葡聚糖/透明质酸共聚物治疗膀胱输尿管反流的成本效益
J Urol. 2003 Apr;169(4):1480-4; discdussion 1484-5. doi: 10.1097/01.ju.0000056638.75652.54.
10
Appearance of dextranomer/hyaluronic Acid copolymer implants on computerized tomography after endoscopic treatment of vesicoureteral reflux in children.儿童膀胱输尿管反流内镜治疗后葡聚糖凝胶/透明质酸共聚物植入物在计算机断层扫描上的表现
J Urol. 2009 Mar;181(3):1324-8; discussion 1329. doi: 10.1016/j.juro.2008.11.036. Epub 2009 Jan 20.

引用本文的文献

1
Exploratory trial of urethral submucosa injection therapy of deflux for stress urinary incontinence after radical prostatectomy.根治性前列腺切除术后压力性尿失禁的尿道黏膜下层注射德芙康治疗探索性试验。
Int J Surg Protoc. 2024 Oct 30;28(4):1-6. doi: 10.1097/SP9.0000000000000031. eCollection 2024 Oct 21.
2
Migrating foreign material mimicking metastatic soft tissue sarcoma in a patient with history of synthol injection.在有合成醇注射史的患者中,迁移的异物酷似转移性软组织肉瘤。
Radiol Case Rep. 2024 Sep 13;19(12):5828-5833. doi: 10.1016/j.radcr.2024.08.089. eCollection 2024 Dec.
3
The treatment of vesicoureteral reflux in children by endoscopic sub-mucosal intra-ureteral injection of dextranomer/hyaluronic acid: A case-series, multi-centre study.
内镜下输尿管黏膜下注射葡聚糖/透明质酸治疗儿童膀胱输尿管反流:一项病例系列多中心研究
Electron Physician. 2017 Apr 25;9(4):4145-4149. doi: 10.19082/4145. eCollection 2017 Apr.
4
Comparison of histopathological characteristics of polyacrylate polyalcohol copolymer with dextranomer/hyaluronic acid after injection beneath the bladder mucosa layer: a rabbit model.膀胱黏膜下层注射聚丙烯酸多元醇共聚物与葡聚糖/透明质酸后组织病理学特征比较:兔模型
Int Urol Nephrol. 2017 May;49(5):747-752. doi: 10.1007/s11255-017-1540-z. Epub 2017 Feb 16.
5
The outcomes of two different bulking agents (dextranomer hyaluronic acid copolymer and polyacrylate-polyalcohol copolymer) in the treatment of primary vesico-ureteral reflux.两种不同填充剂(葡聚糖-透明质酸共聚物和聚丙烯酸-多元醇共聚物)治疗原发性膀胱输尿管反流的疗效
Int Braz J Urol. 2016 May-Jun;42(3):514-20. doi: 10.1590/S1677-5538.IBJU.2015.0274.
6
Efficacy of dextranomer hyaluronic acid and polyacrylamide hydrogel in endoscopic treatment of vesicoureteral reflux: A comparative study.葡聚糖凝胶透明质酸和聚丙烯酰胺水凝胶在内镜下治疗膀胱输尿管反流中的疗效:一项对比研究。
Can Urol Assoc J. 2015 May-Jun;9(5-6):202-6. doi: 10.5489/cuaj.2964.
7
Long-term efficacy of NASHA Dx injection therapy for treatment of fecal incontinence.NASHA Dx注射疗法治疗大便失禁的长期疗效。
Neurogastroenterol Motil. 2014 Aug;26(8):1087-94. doi: 10.1111/nmo.12360. Epub 2014 May 19.
8
Long-term results after endoscopic VUR-treatment using dextranomer / hyaluronic acid copolymer - 5-year experience in a single-center.使用葡聚糖omer/透明质酸共聚物进行内镜下膀胱输尿管反流治疗的长期结果——单中心5年经验
Cent European J Urol. 2011;64(2):84-6. doi: 10.5173/ceju.2011.02.art7. Epub 2011 Jun 2.
9
Endoscopic treatment of vesicoureteric reflux with dextranomer/hyaluronic acid copolymer (Deflux): Single-surgeon experience with 48 ureters.使用葡聚糖/透明质酸共聚物(Deflux)进行膀胱输尿管反流的内镜治疗:一位外科医生对48条输尿管的经验。
Indian J Urol. 2013 Jul;29(3):173-6. doi: 10.4103/0970-1591.117269.
10
Factors that impact the outcome of endoscopic correction of vesicoureteral reflux: a multivariate analysis.影响内镜下治疗膀胱输尿管反流疗效的因素:多因素分析。
Int Urol Nephrol. 2013 Feb;45(1):1-9. doi: 10.1007/s11255-012-0327-5. Epub 2012 Nov 17.